about
Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature.Survival After Varying Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: A Pairwise and Network Meta-Analysis.Left Anterior Descending Artery Myocardial Bridging: A Clinical Approach.Echocardiographic follow-up after transcatheter aortic valve replacement.Impact of Changes in Left Ventricular Ejection Fraction on Survival After Transapical Aortic Valve Implantation.Early and Midterm Outcome of Propensity-Matched Intermediate-Risk Patients Aged ≥80 Years With Aortic Stenosis Undergoing Surgical or Transcatheter Aortic Valve Replacement (from the Italian Multicenter OBSERVANT Study).Intermediate Clinical and Hemodynamic Outcomes After Transcatheter Aortic Valve Implantation.Effect on Clinical Restenosis of an Ultra-Thin-Strut Bare Metal Cobalt-Chromium Stent Versus a Thin-Strut Stainless Steel Stent.Meta-analysis of comparison between self-expandable and balloon-expandable valves for patients having transcatheter aortic valve implantation.Another passenger for the TAVR speeding train.Transcatheter aortic valve implantation at institutions without cardiovascular surgery departments: many questions still linger before a paradigm shift.Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantation.Time-dependent detrimental effects of distal embolization on myocardium and microvasculature during primary percutaneous coronary intervention.[The CHOICE study].Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry.Development and Validation of a Distal Embolization Risk Score During Primary Angioplasty in ST-Elevation Myocardial Infarction.Balloon aortic valvuloplasty in the era of transcatheter aortic valve replacement: acute and long-term outcomes.Expanding the eligibility for transcatheter aortic valve implantation the trans-subclavian retrograde approach using: the III generation CoreValve revalving system.Comparison of balloon-expandable versus self-expandable valves for transcatheter aortic valve implantation in patients with low-gradient severe aortic stenosis and preserved left ventricular ejection fraction.Transfemoral aortic valve implantation of an Edwards Sapien XT valve in a patient with a mechanical mitral prosthesis.Long-term outcomes and prosthesis performance after transcatheter aortic valve replacement: results of self-expandable and balloon-expandable transcatheter heart valves.1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.TAVR with mechanically expandable prostheses: Is balloon aortic valvuloplasty really necessary?Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed By Six- Versus Twelve-Month Dual Antiplatelet TPerformance of valve-in-valve for severe para-prosthetic leaks due to inadequate transcatheter aortic valve implantation.Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.Coronary stent implantation for an acute iatrogenic ascending aortic dissection.Optimization of left ventricular pacing site plus multipoint pacing improves remodeling and clinical response to cardiac resynchronization therapy at 1 year.Determination of the longest intrapatient left ventricular electrical delay may predict acute hemodynamic improvement in patients after cardiac resynchronization therapy.Ventricular assist devices.Impact of myocardial staining on In-hospital outcome after primary percutaneous coronary intervention in the Padua Registry on ST-elevation myocardial infarctionAcute coronary syndrome with clear coronary artery: the case for concealed coronary hematomaMyocardial abnormalities underlying persistent ST-segment elevation after anterior myocardial infarctionPredictors and time-related impact of distal embolization during primary angioplastyIncidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantationValve replacement for severe aortic stenosis with low transvalvular gradient and left ventricular ejection fraction exceeding 0.50Totally percutaneous valve replacement for severe aortic regurgitation in a degenerating bioprosthesisPercutaneous coronary intervention for unprotected left main disease in very high risk patients: safety of drug-eluting stentsMultipoint pacing by a left ventricular quadripolar lead improves the acute hemodynamic response to CRT compared with conventional biventricular pacing at any site
P50
Q38090308-39619AC2-10ED-42D9-92B1-6A797FCD595EQ38949750-1F1C31BF-F3B1-448E-83BA-1A2A1D678D52Q39050587-5D5B4BE8-A3D3-4130-B0F0-B33486485E95Q39067242-1E98176B-24C3-4630-A30C-CF647BFF937BQ39403740-B012C0B1-6ABE-46B5-A95F-7FB44F333955Q39906543-CA376A05-E62A-4F8D-A87F-F0CA4BC021CAQ40279533-CCBDECF3-69A4-4B6F-BEDD-CBFF2C481870Q40727759-60D44B5B-FB36-4FDF-8BEE-DE9BF7B5E40EQ41044616-3B9FE9FA-5D58-458D-9359-E4E6A2AAD379Q42348603-A6994019-1F30-4980-89E4-8494B0C7E162Q42384657-E301289A-658C-4FE3-8D43-EFA6C4DCF4B5Q43473032-0450E3AD-FD71-420B-A03E-1F131126D647Q43919050-164FDE4B-0F72-4989-BA67-3D045CEA92FDQ44048707-F58D356F-CCC1-498B-B470-93541D015540Q44431195-5A881D96-B692-4E7E-8CE3-250E129180D5Q44764816-0161AC48-05A0-4765-9EC7-82EBD5B2A744Q45067507-369C2290-04DA-4900-8111-8BD2DCE16AD0Q46043451-B91FE6AA-28A9-448E-8E6F-1F6D51683DF7Q46115757-8B6A5B42-4A8D-49DC-AED6-36B00A1D7440Q46143359-C7CBDDCD-A8FB-4AF5-90BF-EB8E9F45043CQ46734700-168C605D-218F-4B6E-8BBA-72E6676427EAQ47208395-DFDDC97D-00B2-40E3-ADD5-A6245F7ACFF2Q47652606-366A1BE3-D758-4CCF-B490-B12437C6AF14Q48290665-A928C0CF-3882-44BE-BF85-22F7CD88B877Q50938916-C2A3FB95-E387-40E5-B519-83A1D42BE1BEQ50990972-C6A44929-8E2A-47A4-8A3F-451F3051D423Q51752063-34D47656-B18A-4BEB-8654-4ECC7A084C3CQ53059463-4D73579F-E4B0-404F-A45E-626C88625160Q53588144-14403F95-AAAD-43AB-B50C-783D2B10E049Q53590000-E04131E1-BAFC-4AC0-8406-0A9FF4B5CB88Q53668606-A8E2BF8B-91C7-4BFA-AD41-E4B098815004Q62716936-EC6B8924-8B06-49AD-BB9D-063A7826CE93Q82505753-D11A9402-8883-47C1-9E89-79EA602B174DQ83188244-BB046838-49BB-42FE-8AF8-BBB0396CBF02Q83202704-EA7DC684-E66C-495F-804A-BA01AFF2ADCBQ83236893-A558B6C4-2792-45D8-BBD4-512AE50E735DQ84211400-B9084D62-233E-40FE-B6C3-E25B488875D4Q84362012-1A1CE1FC-A079-4EAF-878A-481F784436BBQ85233183-02807604-0754-4A9A-8F04-DCAAA6869574Q86607956-F01C2973-C908-4BAA-ADB3-F873CF900AE9
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Chiara Fraccaro
@ast
Chiara Fraccaro
@en
Chiara Fraccaro
@es
Chiara Fraccaro
@nl
type
label
Chiara Fraccaro
@ast
Chiara Fraccaro
@en
Chiara Fraccaro
@es
Chiara Fraccaro
@nl
prefLabel
Chiara Fraccaro
@ast
Chiara Fraccaro
@en
Chiara Fraccaro
@es
Chiara Fraccaro
@nl
P106
P21
P214
25144928028454340616
P31
P496
0000-0002-3972-4642
P5008
P735
P7859
viaf-25144928028454340616